IS7339A - Aðferð til framleiðslu á 7alfa-metýlsterum - Google Patents

Aðferð til framleiðslu á 7alfa-metýlsterum

Info

Publication number: IS7339A
Authority: IS; Iceland
Prior art keywords: 7alpha; producing; methyl esters; esters; methyl
Prior art date: 2002-01-21

Application number

IS7339A

Other languages

English (en)

Other versions

IS2740B (is

Inventor

Stoelwinder J.

Ostendorf M.

Van Buggenum P.A.M.

Original Assignee

Akzo Nobel N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-21

Filing date

2004-06-28

Publication date

2004-06-28

2004-06-28 Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.

2004-06-28 Publication of IS7339A publication Critical patent/IS7339A/is

2011-06-15 Publication of IS2740B publication Critical patent/IS2740B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)

IS7339A 2002-01-21 2004-06-28 Forskautsbygging rafgreiningarkera til þess að framleiða ál með tilheyrandi kerskála IS2740B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02075230		2002-01-21
PCT/EP2003/000339 WO2003059931A1 (en)	2002-01-21	2003-01-14	PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS

Publications (2)

Publication Number	Publication Date
IS7339A true IS7339A (is)	2004-06-28
IS2740B IS2740B (is)	2011-06-15

Family

ID=8185555

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7339A IS2740B (is)	2002-01-21	2004-06-28	Forskautsbygging rafgreiningarkera til þess að framleiða ál með tilheyrandi kerskála

Country Status (28)

Country	Link
US (2)	US20050090476A1 (is)
EP (1)	EP1470151B1 (is)
JP (1)	JP5250174B2 (is)
KR (1)	KR100937179B1 (is)
CN (1)	CN100372864C (is)
AR (1)	AR038165A1 (is)
AT (1)	ATE453659T1 (is)
AU (1)	AU2003205604B8 (is)
BR (1)	BRPI0306736B8 (is)
CA (1)	CA2472379C (is)
DE (1)	DE60330749D1 (is)
EC (1)	ECSP045180A (is)
EG (1)	EG23417A (is)
ES (1)	ES2336439T3 (is)
HR (1)	HRP20040634B1 (is)
IL (2)	IL162770A0 (is)
IS (1)	IS2740B (is)
MX (1)	MXPA04007049A (is)
NO (1)	NO327095B1 (is)
NZ (1)	NZ533970A (is)
PE (1)	PE20030926A1 (is)
PL (1)	PL208163B1 (is)
RO (1)	RO122913B1 (is)
RS (1)	RS51490B (is)
RU (1)	RU2305105C2 (is)
TW (1)	TWI322813B (is)
WO (1)	WO2003059931A1 (is)
ZA (1)	ZA200405257B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10213371C1 (de) *	2002-03-21	2003-12-24	Schering Ag	Verfahren zur Herstellung von 7alpha-Methylsteroiden
GB0304927D0 (en) *	2003-03-04	2003-04-09	Resolution Chemicals Ltd	Process for the production of tibolone
DE10352433B4 (de)	2003-11-10	2012-10-11	Nanotecmarin Gmbh	Polypeptid eines Silicatein-ß aus Suberites domuncula, dafür kodierende Nukleinsäure, deren Verwendungen, diese Nukleinsäure umfassender Vektor und dieses Polypeptid exprimierende Wirtszelle
KR100716981B1 (ko) *	2004-09-30	2007-05-10	삼성전자주식회사	대중교통의 최적경로 검색방법 및 이를 이용한 휴대용 기기
JP5749261B2 (ja) *	2009-06-29	2015-07-15	メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー	３，３，５，５−テトラメチルシクロヘキサノンを調製する方法
CN111944001A (zh) *	2020-07-09	2020-11-17	浙江神洲药业有限公司	一种替勃龙的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3341557A (en) *	1961-06-05	1967-09-12	Upjohn Co	7-methyltestosterones
US3470216A (en) *	1966-11-29	1969-09-30	Du Pont	Selected 17,17-difluoro unsaturated androstanes
FR2054527B1 (is) *	1969-07-28	1973-06-08	Roussel Uclaf
US3798213A (en) *	1971-01-25	1974-03-19	Merck & Co Inc	7 alpha-methyl-20-spiroxane-3-ones and process
DE2558088C2 (de) *	1975-12-19	1985-05-30	Schering AG, 1000 Berlin und 4709 Bergkamen	Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
JPS56145239A (en) *	1980-04-11	1981-11-11	Sumitomo Chem Co Ltd	Novel bicyclooctane derivative and its preparation
US4298559A (en) *	1980-07-23	1981-11-03	Dow Corning Corporation	High yield silicon carbide from alkylated or arylated pre-ceramic polymers
US6054446A (en) *	1997-12-24	2000-04-25	Sri International	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) *	1997-12-24	2003-04-15	Sri International	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
ES2204613T3 (es) *	1999-04-06	2004-05-01	Akzo Nobel N.V.	Androgenos 7-alfa alquilo oralmente activos.
TW548277B (en) *	1999-07-16	2003-08-21	Akzo Nobel Nv	Orally active androgens
CZ301376B6 (cs) *	1999-12-02	2010-02-03	N.V. Organon	Steroidní deriváty s androgenním úcinkem
US6784170B2 (en) *	2000-02-11	2004-08-31	Sri International	Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
AU2001282016B2 (en) *	2000-07-28	2005-11-10	N.V. Organon	16alpha-methyl or ethyl substituted estrogens
US20040010138A1 (en) *	2002-03-21	2004-01-15	Schering Ag	Process for the production of 7alpha-methyl steroids
US7304157B2 (en) *	2004-09-28	2007-12-04	Bristol-Myers Squibb Company	Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

2003
- 2003-01-14 IL IL16277003A patent/IL162770A0/xx unknown
- 2003-01-14 PL PL371583A patent/PL208163B1/pl unknown
- 2003-01-14 RS YUP-630/04A patent/RS51490B/sr unknown
- 2003-01-14 BR BRPI0306736A patent/BRPI0306736B8/pt not_active IP Right Cessation
- 2003-01-14 KR KR1020047010985A patent/KR100937179B1/ko not_active Expired - Lifetime
- 2003-01-14 DE DE60330749T patent/DE60330749D1/de not_active Expired - Lifetime
- 2003-01-14 EP EP03702441A patent/EP1470151B1/en not_active Expired - Lifetime
- 2003-01-14 ES ES03702441T patent/ES2336439T3/es not_active Expired - Lifetime
- 2003-01-14 US US10/502,259 patent/US20050090476A1/en not_active Abandoned
- 2003-01-14 TW TW092100693A patent/TWI322813B/zh not_active IP Right Cessation
- 2003-01-14 NZ NZ533970A patent/NZ533970A/en not_active IP Right Cessation
- 2003-01-14 CA CA2472379A patent/CA2472379C/en not_active Expired - Lifetime
- 2003-01-14 HR HRP20040634AA patent/HRP20040634B1/hr not_active IP Right Cessation
- 2003-01-14 WO PCT/EP2003/000339 patent/WO2003059931A1/en not_active Ceased
- 2003-01-14 AU AU2003205604A patent/AU2003205604B8/en not_active Expired
- 2003-01-14 RO ROA200400656A patent/RO122913B1/ro unknown
- 2003-01-14 MX MXPA04007049A patent/MXPA04007049A/es active IP Right Grant
- 2003-01-14 CN CNB038024918A patent/CN100372864C/zh not_active Expired - Lifetime
- 2003-01-14 JP JP2003560033A patent/JP5250174B2/ja not_active Expired - Lifetime
- 2003-01-14 RU RU2004125580/04A patent/RU2305105C2/ru active
- 2003-01-14 AT AT03702441T patent/ATE453659T1/de not_active IP Right Cessation
- 2003-01-19 EG EG2003010051A patent/EG23417A/xx active
- 2003-01-20 PE PE2003000062A patent/PE20030926A1/es active IP Right Grant
- 2003-01-20 AR ARP030100149A patent/AR038165A1/es unknown
2004
- 2004-06-28 IS IS7339A patent/IS2740B/is unknown
- 2004-06-29 IL IL162770A patent/IL162770A/en active IP Right Grant
- 2004-07-01 ZA ZA2004/05257A patent/ZA200405257B/en unknown
- 2004-07-06 EC EC2004005180A patent/ECSP045180A/es unknown
- 2004-08-19 NO NO20043455A patent/NO327095B1/no not_active IP Right Cessation
2010
- 2010-04-22 US US12/765,629 patent/US20100204497A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HRP20040634A2 (en)	2004-10-31
BRPI0306736B1 (pt)	2017-11-07
KR100937179B1 (ko)	2010-01-19
JP5250174B2 (ja)	2013-07-31
AU2003205604B2 (en)	2009-11-26
WO2003059931A1 (en)	2003-07-24
EP1470151A1 (en)	2004-10-27
TW200302731A (en)	2003-08-16
RS51490B (sr)	2011-04-30
RU2004125580A (ru)	2006-01-27
US20100204497A1 (en)	2010-08-12
ES2336439T3 (es)	2010-04-13
IS2740B (is)	2011-06-15
EG23417A (en)	2005-06-28
RO122913B1 (ro)	2010-04-30
CN100372864C (zh)	2008-03-05
PE20030926A1 (es)	2003-10-29
US20050090476A1 (en)	2005-04-28
JP2005519899A (ja)	2005-07-07
PL371583A1 (en)	2005-06-27
NZ533970A (en)	2005-10-28
HRP20040634B1 (hr)	2013-07-31
RU2305105C2 (ru)	2007-08-27
IL162770A (en)	2011-06-30
NO327095B1 (no)	2009-04-20
TWI322813B (en)	2010-04-01
DE60330749D1 (de)	2010-02-11
IL162770A0 (en)	2005-11-20
CN1863814A (zh)	2006-11-15
CA2472379A1 (en)	2003-07-24
YU63004A (sh)	2006-08-17
AR038165A1 (es)	2004-12-29
CA2472379C (en)	2010-05-25
EP1470151B1 (en)	2009-12-30
AU2003205604A1 (en)	2003-07-30
BRPI0306736B8 (pt)	2021-05-25
KR20040077727A (ko)	2004-09-06
ECSP045180A (es)	2004-08-27
ZA200405257B (en)	2005-08-31
BR0306736A (pt)	2004-12-28
PL208163B1 (pl)	2011-03-31
MXPA04007049A (es)	2004-10-14
AU2003205604B8 (en)	2009-12-24
ATE453659T1 (de)	2010-01-15
NO20043455L (no)	2004-08-19

Publication	Publication Date	Title
DK1467993T3 (da)	2008-11-10	Fremgangsmåde til fremstilling af scopinestere
FI20031301L (fi)	2005-03-12	Esteröintimenetelmä
BRPI0313238A2 (pt)	2016-06-21	método
BR0313190B1 (pt)	2013-04-02	mÉtodo para produzir um Éster carbânico.
PL1697390T3 (pl)	2008-04-30	Sposób wytwarzania organoacylofosforynów
FI20021560A0 (fi)	2002-09-02	Ohjausmenetelmä
IS7981A (is)	2005-08-15	Aðferð til að framleiða örkerfi
FI20021114L (fi)	2003-12-12	Menetelmä raakakuparin valmistamiseksi
IS7339A (is)	2004-06-28	Aðferð til framleiðslu á 7alfa-metýlsterum
FI20030380L (fi)	2004-09-15	Menetelmä prosessin säätämiseksi
EP1634958A4 (en)	2008-01-02	PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN CARBOXYLATE
NO20043760L (no)	2004-11-09	Fremgangsmate til fremstilling av olefiner
NO20035626D0 (no)	2003-12-17	Metode
NO20023358D0 (no)	2002-07-11	Metode
IL173238A0 (en)	2006-06-11	Methods for producing tetrabromobenzoate esters
DE10394362D2 (de)	2006-09-21	Method for the operation of a technical system
FI20030381L (fi)	2004-09-15	Menetelmä prosessin säätämiseksi
EP1556396A4 (en)	2007-10-24	METHOD OF PRODUCING 2-DESOXY-L-RIBOSE
ITMI20021432A0 (it)	2002-06-28	Metodo per produrre cefalosporine
IS8088A (is)	2005-10-24	Aðferð til að framleiða imídasópýridín-8-ón
IL175238A0 (en)	2006-09-05	Method for producing 4-pentafluoride-sulfanyl-benzoylguanidines
PL359838A1 (pl)	2004-11-02	Sposób wytwarzania nano-ścieżek
NO20035692D0 (no)	2003-12-19	Produksjonsmetode
FI20021421A0 (fi)	2002-07-30	Valmistusmenetelmä
FI20022301A0 (fi)	2002-12-31	Asettamismenetelmä